Arteris (AIP) is back in focus after SiEngine Technology licensed its FlexNoC network on chip interconnect IP for a next generation automotive SoC platform targeting intelligent cockpit, ADAS, and AI driven cockpit drive fusion.

Despite the SiEngine announcement keeping Arteris in the headlines, the stock has been volatile in the short term, with the 1 day share price return down 19.97% and the 7 day share price return down 19.01%. At the same time, the 90 day share price return of 92.64% and year to date share price return of 125.03% point to strong upward momentum, supported by a 1 year total shareholder return of 279.85% and a 3 year total shareholder return of 408.12% at a latest share price of US$35.06.

If Arteris has you looking at how AI is reshaping chips and software, it can be worth broadening your watchlist with other 30 AI small caps

After such a sharp move higher in Arteris and with mixed external opinions on its valuation, the key question is whether today’s price still leaves room for upside or if the market is already pricing in future growth.

Most Popular Narrative: 7.1% Undervalued

The most followed narrative on Arteris compares a fair value of $37.75 to the latest close at $35.06, suggesting the market is sitting modestly below that reference point while expectations around AI related licensing and royalties do a lot of the heavy lifting.

The ongoing industry transition to chiplet-based and heterogeneous integration architectures is expanding Arteris' addressable market, with chiplet-related design starts expected to rise from 5% to 30% in coming years. This structural trend supports both higher sales volume and increased average selling prices, benefiting future top-line revenue.

Want to see what sits behind that fair value for Arteris? The most followed narrative leans on rapid revenue expansion, improving margins, and a rich future earnings multiple. The full breakdown spells out exactly which assumptions need to hold for that price to stack up.

Result: Fair Value of $37.75 (UNDERVALUED)

However, Arteris still faces meaningful risks, including reliance on a handful of large licensing deals and continued operating losses that could weigh on sentiment if its pace of expansion slows.

Another View on Arteris Using Sales Multiples

The fair value story for Arteris built around earnings expectations runs into a very different picture when you look at simple sales-based pricing. On a P/S of 21x versus 4.2x for peers, 3.5x for the US Software industry, and a fair ratio of 7.5x, the stock sits at a steep premium that could matter if sentiment cools.

For investors weighing that premium against the AI growth narrative, it is worth asking how much optimism is already baked into the price and what happens if expectations are merely met rather than exceeded, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With mixed signals around Arteris right now, are you prepared to move quickly and base your view on the data rather than the headlines? To weigh the concerns against the potential rewards in one place, start by reviewing the 1 key reward and 3 important warning signs

Looking for more investment ideas beyond Arteris?

If Arteris has sharpened your appetite for focused research, do not stop here. Widen your opportunity set now with a few targeted stock idea lists.

• Zero in on companies that trade below their assessed worth by scanning through carefully filtered 43 high quality undervalued stocks that may merit a closer look.
• Strengthen your income stream by reviewing 7 dividend fortresses that aim to combine higher yields with relatively durable business profiles.
• Reduce portfolio stress by checking 75 resilient stocks with low risk scores selected for resilient balance sheets and more stable risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.